Consequently, AKT1 inhibition by a‐674563 strongly blocked its downstream signaling and significantly enhanced DAV‐induced cell death in AML cells and primary cells from patients with AML (Figure 4K,L; S3D–F, Supporting Information). The gene discussed is AKT1; the disease is acute myeloid leukemia.